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1. Introduction 
The incidence of breech presentation is 3-4% (Enkin et al 1995). It is still debated what is the 
best performance. In particular, both the role of the external cephalic version and the birth 
type have been extensively debated.  
In contrast to cephalic presentations, breech presentations has a higher mortality and 
morbidity due to the associated incidence of prematurity, congenital malformations or intra-
partum asphyxia.  Thus, many efforts have been made in order to establish the best 
performance regarding the birth type: either vaginal delivery (in those women selected after 
evaluating different fetal and pelvic parameters) or the elective caesarian. On the other 
hand, the external version can be also considered. (American College Obstetricians and 
gynecologist [ACOG], 2001). It aims to avoid the vaginal delivery or caesarian complications 
by turning a breech presentation into a cephalic presentation.   
Breech presentation is an independent factor associated with higher morbidity (Royal 
College of Obstetricians and Gynaecologists [RCOG], 2006). In fact, a high prevalence rate in 
children disabilities after breech presentation (16%) has been registered both in vaginal and 
caesarean delivery (Danielian et al, 1996).  
Traditionally, there has always been a general agreement on the preference of caesarian 
delivery instead of a elective vaginal delivery in case of breech babies in the following 
circumstances: feet first, large fetus, intrapartum risk of loss of fetal well-being, congenital 
malformations (meaning a mechanical problem for a vaginal delivery) or in case of 
inexperienced obstetricians.  
Some obstetricians advocate caesarean intervention in order to reduce the perinatal risks 
associated with breech presentation. Unfortunately this is based on their personal 
experience, medical legal aspects and non-randomized studies. Nevertheless, other 
obstetricians still advocate for vaginal delivery in selected cases, as it may reduce the 
maternal morbidity and the use of medical resources. In 2000, the results of a 
multicentric and randomized clinical study conducted by Hannah et al. in collaboration 
with The Term Breech Trial were published in The Lancet (Hannah et al, 2000). In this 
study, the caesarean delivery was highly recommended in breech babies at term.  The 
Cochrane database also published a meta-analysis including Hannah’s project (Hofmeyr 
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et Hannah, 2003). This analysis concluded that the elective caesarean reduces both the 
perinatal and neonatal morbidity and mortality at the expense of a moderate increase in 
maternal morbidity.  
This study led to a worldwide change in medical practice. Several national recommended 
the caesarean delivery in term breech babies. In fact, in many American and European 
countries, this performance has become the only one to be considered.  
In view of this opinion about avoiding the vaginal delivery in breech babies by using the 
caesarian delivery, there has been a growing interest in retaking the external version 
performances in order to reduce the caesarian delivery frequency.  
Definitely, the external version has become more and more relevant as well as a 
controversial and a topical issue since this is a valid option against the elective caesarian.  It 
has been shown that its use significantly reduces the vaginal delivery frequency as well as 
the caesarian delivery frequency in breech presentation in full term pregnancies.   In spite of 
this fact, the external version is still not implemented in many countries.  
This review article aims to discuss the complications in breech babies and the use of external 
version as an alternative (regarding the process itself, the conditions and the right moment 
to perform it, its contraindications, its adverse effects, etc.). 
2. Material and methods 
Articles have been searched in Medline and Pubmed database as well as in the Cochrane 
Database of Systematic Reviews.  The search has been limited to those studies in human beings 
and articles in English or Spanish developed between 1995 and 2007. Current clinical 
practice guidelines (from the –American, British, Canadian and Spanish national 
associations of obstetricians and gynecologists  on external version and breech presentation 
have also been reviewed. Key words:  Breech, cephalic version, external version, adverse 
event “and” cephalic version.   
3. Breech presentation 
Breech presentation is defined as a fetus in a longitudinal lie with the buttocks or feet closest 
to the cervix and the head closest to the fundus of the uterus.  There are three types of 
breeches. 
The incidence of breech presentation in neonates before the 28th gestation-week is 20%. This 
percentage decreases to 3-4% with advancing gestational age.  These data show that most 
babies turn around during the third trimester of pregnancy.  Under normal circumstances, 
as the shape of the uterus changes, the fetus turns simultaneously to headfirst position 
between the 28th and the 32nd week of pregnancy.  As of this moment, the uterus will 
expand more vertically than transversely. This situation facilitates the previous fetal 
position.  Although the simultaneous turn is more common during the weeks of pregnancy 
mentioned above, this turn is also possible at delivery. However, this is more common in 
multiparous women rather than in primiparous women.   Thus, it seems that the fetus plays 
an active role at adopting the best position in the uterus.   
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A. B. C. 
Fig. 1. A. Frank breech (65-70%) The baby’s legs are flexed at the hip, his or her knees are 
extended and feet next to the head.  This is the most common type in pregnancies at term. B. 
Complete breech (5%) In this case, the baby’s hips and knees are flexed. The fetus positions 
is the same as in the vertex presentation but, in this case, the polarity is reversed.  C. 
Incomplete breech (-30%) The baby has one or both knees flexed so that baby’s legs (not his 
or her bottom) are poised to deliver first.  This type is common in preterm deliveries. 
From the etiologic point of view, the breech presentation could be caused by situations 
avoiding or hampering the spontaneous cephalic version.  
 Fetal factors: Prematurity, low weight, multiple pregnancy, structural anomalies, 
chromosomopathies, reduced fetal mobility. 
 Maternal factors: Primiparous women, uterine malformations that change the uterus 
normal morphology, previous tumour, pelvic stenosis. 
 Ovular factors: Anomalies of placental insertion (placenta previa), short umbilical cord 
and the changes in the amniotic fluid volume (both oligohydramnios and 
polyhydramnios). 
The incidence of breech presentation is closely related to the gestational age. In the case of 
single-gestation pregnancies, the preterm delivery is probably the aspect that contributes the 
most to a breech presentation at delivery. Before the 28th week, the incidence is almost 10 
times higher than at term, and almost 12% of preterm deliveries show breech presentation. 
However, 50%-80% of the cases do not show any etiologic factor responsible for the breech 
presentation (Sociedad Española de Ginecología y Obstetricia [SEGO], 2001). 
4. The term breech trial: Clinical practice implications  
The article: “Elective caesarean vs. vaginal delivery with breech presentation at term: The 
International Term Breech Trial”, was a randomized trial published by Hannah et al. in The 
Lancet magazine in 2000. The conclusions of the study were immediately adopted by the 
medical society, leading to a great change in obstetric practice. 
The purpose of the study was to create a clinical guideline based on the evidence regarding 
the best performance to follow with respect to breech presentation.  The study was carried 
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out in 121 centres of 26 different countries. It included a total of 2008 pregnant women at 
term with breech babies. Those women were randomly given the date of the planned 
caesarean or the planned vaginal delivery. After a three-month monitoring, it was 
performed a two-year monitoring.  
There was a reduction in the neonatal mortality and morbidity in the elective caesarean 
delivery group when compared with the elective vaginal delivery group, without any 
significant increase of maternal morbidity or mortality. Furthermore, it was found that the 
adverse perinatal outcomes were less common when the caesarean had been planned before 
delivery, while they increased if the caesarean was performed intrapartum. 
The subgroup analysis failed to demonstrate any independent association with deliveries 
performed after long delivery labor, those oxytocin or prostaglandin induced, those cases of 
incomplete breech presentation, those with unknown breech presentation and those breech 
presentation deliveries performed by inexperienced obstetricians.  
Another subgroup analysis was carried out according to the national perinatal mortality rate 
(low versus high). In this case, the results showed some changes, obtaining a higher 
reduction of perinatal mortality in countries with lower national perinatal mortality rate 
than in those with higher mortality rates. Therefore, the benefits of the at term caesarean 
will be higher in countries with lower perinatal mortality rates, as it is the case of Spain. One 
reason for this difference could be that, in these countries, women were discharged at an 
early stage after the vaginal delivery. Therefore, the collection of neonatal complications has 
been less complete than the records concerning caesarean-born babies, as they need to stay 
longer in the hospital.  
All subgroups analysis, except the already mentioned one, showed similar risk reductions 
when using an elective caesarean delivery, compared with the planned vaginal deliveries of 
the main study (Hannah et al, 2002). 
Concerning maternal morbidity, the urinary incontinence occurring three months after 
delivery was lower in the planned caesarean group. Abdominal pain was more common in 
the planned caesarean group, while perineal pain was more common in the planned vaginal 
delivery. There were not statistically significant differences  in low back pain, faecal 
incontinence, postpartum depression, maternal dissatisfaction with the method of care, 
breastfeeding, bonding with the newborn, bonding with the woman’s partner or 
dyspareunia. However, neither the morbidity associated to uterine scars in subsequent 
pregnancies nor the ability to carry out everyday activities were evaluated.  
As it has been mentioned, the results of the analysis of Hannah's three month after delivery 
study yield an significant impact for obstetrician practice and were adopted almost 
immediately by the medical societies. The Cochrane database also published a meta-analysis 
including Hannah’s project. This analysis concluded that the planned caesarean reduces both 
the perinatal and neonatal morbidity and mortality at the expense of a moderate increase in 
maternal morbility. These conclusions were included in the national associations of 
obstetrics and gynecology’s clinical guidelines and protocols. Some of these societies are the 
Royal College of Obstetricians and Gynaecologists (RCOG), the Society of Obstetricians and 
Gynaecologists of Canada (SOGC) or the American College of Obstetricians and 
Gynaecologists (ACOG).  Obviously, the Spanish Society of Obstetrics and Gynaecology 
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(SEGO, as per its Spanish initials) also included these conclusions and recommended in its 
breech presentation protocol the fact of informing the patient about the results from 
previous studies.   This recommendation has caused an increase in breech presentation 
caesarians in pregnancies at term. Thus, a study published in 2003 and carried out in 80 
centres and 23 countries stated that 92% of the centers studies had opted for the caesarean 
delivery in breech presentation instead of the vaginal delivery (Hogle et al, 2003).  
The two year monitoring of this same project (published in 2004) did not show any 
difference between the groups concerning the following aspects: Breast feeding, bonding 
with the newborn or her partner; subsequent pregnancy; incontinence; depression; urinary, 
menstrual or sexual problems; fatigue; or distressing memories of the birth experience. The 
planned caesarean was related to a higher risk of constipation. It is remarkable the fact that 
the mothers from the planned caesarean group showed less concern about their babies' 
health than the ones from the planned vaginal delivery group (Hannah et al, 2004).  
After two years, there were not any differences in the perinatal results between the elective 
caesarean and the elective vaginal delivery, regarding the risk of death or the developmental 
delay in two years old children. In other words, the lower number of neonatal deaths 
observed in the project after three months was compensated with a higher number of 
developmental delay in the elective caesarean delivery group (RCOG, 2006). This was a very 
surprising result, because three months after the project, performing a planned caesarean 
delivery proved a reduction both of risk of perinatal death and of severe neonatal morbidity.  
In conclusion, the planned caesarean delivery is not related to a risk of death reduction or to 
a developmental delay in two year old children, although this reduction is observed until six 
months after birth (whyte et al, 2003). Therefore, this new analysis two years after delivery 
revealed that the initial conclusion could not be maintained, as there were not any 
significant differences in neonatal morbidity and mortality between both groups. These new 
conclusions generated debated regarding the recommendations of The Term Breech Trial as 
the authors continued to reiterate the conclusions from the initial analysis in following 
papers despite the results obtained after the second year. Projects criticising the 
methodological reliability and setting out possible biases in Hannah’s project. Even though, 
both the Cochrane and the different national obstetrics and gynaecology societies that 
adopted the initial results in its recommendations, have not gone into the question again 
since then. This is not surprising, as the breech presentation delivery is related to many risks 
from a medico-legal point of view, which makes the caesarean delivery option seem a more 
convenient option and with lower medico legal risk. Thus, for many obstetricians, Term 
Breech Trial has become an ideal excuse to adopt a type of delivery they already preferred 
over the other one. 
All the aforementioned has resulted in a large increase of the caesarean delivery rates 
over the last few years. For instance, in the United Kingdom, caesarean delivery 
represented 2% of births in 1953, 18% in 1997 and 21% in 2001. In Norway, the rates has 
gone from 12,8% in 1999 to 13,0% in 2000 and 14% in 2001. The highest increase took 
place in the last few months of 2000, concurring with the publication of the Term Breech 
Trial. In the Netherlands, the caesarean delivery rate with breech presentation went from 
50% to 80% in less than two months since the release of the Term Breech Trial (Rietberg 
et al, 2005).   
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This phenomenon must be analyzed, as we cannot obviate the non-negligible maternal risk 
related to caesarean, in spite of having notably decreased in the last few decades, thanks to 
the improvement of the surgical technique, the anesthesia, the infection control, 
thromboembolic prophylaxis, etc.  
The caesarian is the most indendently associated factor with postpartum maternal mortality 
and morbidity (Minkoff et al, 2003). The mortality rate associated to elective caesarean 
almost tripled the vaginal delivery (Hall & Bewley, 1999). It is estimated that caesarean 
(both elective and urgent) quadruple the severe morbidity risks in comparison with vaginal 
delivery (Waterstone et al, 2001). Caesarean also increases the number of hospital 
readmissions. During 1995 and 1998, the Canadian hospital readmission rate during the 
three months after birth (attributable to complications following their birth) was 3,9% for 
caesarean delivery while for vaginal delivery was 2,6% (Health Canada, 2000). An American 
research also revealed higher hospitalization rates after a caesarean, with 1,8 relative risk 
compared with the vaginal delivery (Lydon-Rochelle, 2000).  
Apart from this increase in postpartum morbidity after caesarean, there are also long-term 
risks and complications. The presence of uterine scars increases the risk of complications in 
subsequent pregnancies, such as ectopic pregnancy, placenta praevia, placenta accreta, 
premature placenta detachment and uterine rupture. It has been estimated that every 
caesarean performed to save a child will produce a uterine rupture in the subsequent 
pregnancy (Hodnett et al, 2005). In a project carried out in the Netherlands, it was calculated 
that the increase of 8.500 planned caesarean deliveries, which took place within four years of 
the Term Breech Trial would have avoided 19 perinatal deaths. However, it caused four 
avoidable maternal deaths. In subsequent pregnancies, it could cause 9 perinatal deaths 
caused by uterine rupture and 140 women could suffer complications related to the uterine 
scar (Palencia et al, 2006). The risk of intra-abdominal adhesions, endometriosis on 
implantation and adenomyosis. Caesareans have also been associated to emotional 
problems such as postpartum depression and distressing memories of the birth experience, 
as well as restrictions in everyday activities, and breastfeeding problems. However, it is not 
the case among those women electing the caesarian delivery. It has also been suggested that 
neonatal risks increase in caesarean delivery. Some of these risks are the following: increase 
in admissions to neonatal units (and mother-infant separations postbirth), iatrogenic 
prematurity, increase in neonatal respiratory problems and fetal deaths in the subsequent 
pregnancy. 
In view of this situation, it is obvious the adequacy of the external version in pregnant 
women at term with breech presentation. This is the only performance able to turn a 
breech presentation into a cephalic presentation. Thus, the inherent risk of breech 
presentation delivery (both in vaginal or caesarean delivery) seems to disappear.  A 
review of the strategies followed to reduce the caesarean risks identified the external 
cephalic version (ECV) as the only clinical performance gathering evidence (evidence 
level I) for the total reduction of primary caesarean rates. A Cochrane's review stated 
that the ECV implementation at term (≥ 37th week) increases the probability of cephalic 
presentation at birth and reduces the necessity of a caesarean delivery. Thus, ECV should 
be recommended in the absence of contraindications for every woman with breech 
babies.  
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5. External cephalic version (ECV): Concept and history 
The external cephalic version is an obstetrics performance aiming at turning a breech 
presentation into a cephalic one, more favourable to vaginal delivery.  It can also be used to 
turn a transverse situation into a longitudinal (breech or cephalic) presentation. However, 
its current use is exclusively aimed at turning breech presentation into cephalic 
presentations.  
This performance was widely used before 1970s, but it began to decline because it was 
considered an unsafe method. It has been performed from the time of Hippocrates (460-377 
BC). Aristotle (384-322 BC) was the author of some texts describing that many doctors 
advised midwives to handle the baby's head so that it was presented at birth. 
Over the last century, this performance gradually rose until the sixties, when it saw a 
boom caused by the increasing demand for a less medical intervention at birth.  Before the 
seventies, the cephalic version was performed preterm because it was believed that this 
process could hardly be successful if it was performed at term. The external cephalic 
version was included in the daily obstetric practice due to the obvious and immediate 
effectiveness of the process as well as the results from non-randomized clinical projects.  
Its popularity began to decline in the mid-seventies due to the doubts raised about its 
effectiveness and safety. Reports about a considerable perinatal mortality associated to 
this performance were published (Bradley Watson, 1975) and the caesarian delivery was 
presented as the safest option against the external cephalic version or breech presentation. 
That is the reason why this practice was gradually abandoned until becoming an unusual 
performance.  It must be considered that in those times there were neither ultrasound 
scans nor antenatal monitoring.   
Subsequent projects proved that the external cephalic version in breech babies at term 
significantly reduced non cephalic presentation at birth as well as the rates of caesareans 
with no worse perinatal outcome. This situation, as well as the implantation of the Term 
Breech Trial's results made the external cephalic version be considered as the best option in 
order to avoid the caesarean in breech babies at term. 
6. ECV impact on the reduction of caesarean deliveries and breech 
presentation at birth 
The Cochrane, in a systematic review, assessed the external cephalic version at term effects.  
The results proved a clinically and statistically significant reduction of breech babies as well 
as of caesareans deliveries when the external cephalic version was used. No significant 
effects on perinatal mortality were observed. No significant differences in the incidence on 
Apgar score were observed (7 at the first minute or at the fifth minute, low umbilical artery 
PH level or perinatal death.    
In fact, the Cochrane Foundation recommended offering the external version to every 
woman with normal pregnancies and breeching presentation at term (37th-42nd week) (level 
of recommendation A). 
The cephalic version at term reduces the incidence of breech presentation (risk difference 
52%, NNT 2) as well as the caesarean rate (risk difference 17%, NNT 6) at birth.  In daily 
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clinical practice, most of breech babies are born by elective caesarean, without considering 
the vaginal delivery possibility. That is why the number of caesarians has a further increase 
in daily clinical practice that in the projects. This reduction in the number of caesareans 
continues in spite of the increase of intrapartum caesareans (which has been observed in 
cephalic babies after a successful version in comparison to babies with spontaneous cephalic 
presentation). Furthermore, this increase is regardless of a higher induction rate and it is 
caused by both maternal and fetal indications.  
 
Grade of 
recommendation
Description 
A Body of evidence can be trusted to guide practice 
B Body of evidence can be trusted to guide practice in most situations 
C 
Body of evidence provides some support for recommendation(s) but care 
should be taken in its application 
D 
Body of evidence is weak and recommendation must be applied with 
caution 
Table 1. Definitions of  Grade of Recommendation.  
With respect to the external cephalic version effect on the perinatal outcome, the Cochrane 
data base indicates that, even though no statistically significant differences on perinatal 
mortality were observed, there is not enough evidence to precisely evaluate the risks 
related to the process. More projects must be carried out to determine the adverse effects 
as well as on the external version practice at birth or on the foetuses in non-longitudinal 
situation.  
7. ECV procedure 
Before starting the version, the woman must be informed about the importance of keeping 
calm. She must also know that the procedure can be uncomfortable, although it is not 
painful. The external version cannot be performed without her consent or when the 
abdominal wall shows resistance. For this reason, the woman must be aware of the 
importance of her cooperation. 
 Before the performance, the abdomen is liberally coated with ultrasonic gel in order to 
decrease friction and lessen the chances of an over vigorous manipulation 
First of all, the baby must be moved up and away from the pelvis in the right direction in 
order to increase the fetal flexion. If this manoeuvre is not successful, the next version trial 
must not be carried out.  With both hands on the surface of the baby’s buttocks, they must 
be gently elevated.  It can also be possible to try to move the baby’s head towards one of 
both sides, but this must never be done before the buttocks have been moved.  Sometimes, 
you may need help to handle one of the fetal poles.  The relaxation of the uterus, abdomen 
and legs and the Trendelenburg position will facilitate the maneuver.  
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Secondly, the baby's must be move by palpating the backbone. This can be achieved by 
using both hands simultaneously. While with one hand, the babies feet are moved 
upwards, with the other hand the baby's head must be moved to the opposite side and 
towards the pelvis. The rotation must continue until achieving the optimal vertex position 
(SEGO, 2001).  
It must not be performed any sudden manoeuvres, but moderate and sustained pressure, 
trying that the fetus make the rest of the movement. Basically, the purpose is that the fetus 
itself finds a more comfortable position than the one that it has under pressure. 
   
Fig. 2. Maneuvers to secure the cephalic presentation in fetuses with breech presentation. 
During the maneuver the fetal presentation must be monitored with the ultrasound scan 
and the fetal cardiac frequency with continuous cardiotocography. Transitional fetal 
bradycardia commonly occurs. It is spontaneously solved in most of cases. However, the 
version must be stopped if it is sustained and still continues after relieving the pressure. It 
will also be stopped if it does not succeed after a short period of time or in case of severe 
pain. The benefit of performing the version without anesthesia is that the pain suffered is an 
indicator of the limit of pressure in the maneuver. Furthermore, the use of epidural 
analgesia has not proved neither a greater success in the maneuver, nor a reduction in 
subsequent caesarean rate (Hofmeyr, 2003). After the procedure, the tocolytics perfusion 
will be stopped and the success of the manoeuvre will be confirmed by ultrasound 
scanning. 
Regardless of the success or the failure of the version, the fetal status must be evaluated 
again after performing the procedure. The fetus must be monitored for at least 45 
minutes. If the cardiotocographic record is normal and there is no vaginal bleeding or 
pain, the patient can be discharged, although a 24 hour relative rest will be 
recommended.  
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If this technique does not succeed and the fetus returns to breech presentation, the version 
can be repeated after 5-7 days. It is estimated that 5-10% of the fetus return to the 
presentation previous to the version, as the cause that generated the abnormal presentation 
continues. This spontaneous reversion is more common in multiparous than in nulliparous 
mothers. However, there is no scientific evidence recommending the immediate labor 
induction in order to reduce the possibility of reversion (American College of Obstetricians 
and Gynecologist [ACOG], 2001). 
Rh (-) patients will be given anti-D gamma globulin after the version, as it is estimated that 
the risk of fetomaternal hemorrhage is approximately 1%. 
8. ECV: Prerequisites 
The following prerequisites are necessary before performing an external version:  
 Informed consent signed by the pregnant. 
 Absence of contraindications. 
 Previous checking of fetal wellbeing (reactive NST [Non Stressing Test]). 
 Ultrasound scanning to reveal any contraindications in order to perform the method 
instead of a vaginal delivery. It will also be useful to know: the fetal estimated weight, 
the fetus presentation, position and situation, the amniotic fluid index, and the location 
of the placenta and of the umbilical cord. Using an ultrasound scan while performing 
the maneuver is very advantageous. 
 Performance of the procedure near a operating theatre equipped for an emergency 
caesarean, in case of potential severe complications. 
 The pregnant woman must be placed in the supine position, in semi-Fowler and with a 
light Trendelenburg in order to facilitate the buttocks move. 
 Insertion of an intravenous (IV) to perfuse uterine relaxants (a ritodrine dose of 200 
μg/min). 
9. ECV: Contraindications 
The Spanish, British and Canadian obstetrics and gynaecology association agree that there is 
not enough evidence to draw up a contraindication list. Nevertheless, they do take into 
account some situations that seem to be related to an increase in morbidity and mortality. 
Among them, the following can be considered: 
 Fetal compromise or suspected fetal compromise (abnormal RGTC) 
 Placenta praevia 
 Abruptio placentae  
 Vaginal bleeding in the previous seven days. 
 Oligohydramnios 
 Intrauterine fetal demise.  
 Severe malformations. 
 Rupture of membranes. 
 Multiple gestation. 
 RH isoimmunization. 
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 Severe uterine anomaly.  
 Alterations of coagulation.  
 Existence of some caesarean delivery indicators. 
Determining which situations could be considered as relative contraindications is more 
difficult, but the following are some of them: 
 Hypertensive disorders during pregnancy (preeclampsia with proteinuria). 
 Delayed fetal growth with alteration in uteroplacental Doppler flow. 
 Deflexed fetal head.   
 Estimated weight >3800-4000 grams. 
 Anterior placenta.  
 Already initiated labour. 
 Unstable fetal position. 
 Regarding the previous caesarean, there are not any randomised projects yet, so there 
are not enough data to advise for or against performing it in this situation. 
10. ECV: Predictors and success rate 
The spontaneous version rate in nulliparous women, as of the 36th week, is 8%. However, if 
the version is not successful, this rate is only 5%.  The probability of reversion after a 
successful version is only 5%.  
Depending on the series, the external version success oscillates between 30-80%. This 
success also depends on the race, parity, uterine tone, amniotic fluid volume, cephalic 
engagement, possibility of palpation of cephalic pole and use of tocolytics. The highest 
success rates have been observed in multiparous nonwhite women with relaxed uterus, 
when the breech presentation is not fixed and the cephalic pole can be easily palpated 
(Lau et al, 1997). This would be the optimal condition in order to obtain a successful 
version.  
Many authors have been looking for patterns aiming at predicting the cephalic version 
success or failure (Newman et al, 1993). Those factors considered as the most significant 
tones in a failed external version are the following: the cephalic pole palpation, the 
engagement presentation level and a tense uterus when palpated.   When these factors are 
missing, the probability of a failed external version is only 6%. However, the failure 
probability increases over 80% if more than one of these three factors occurs.  Thus, in a 
group composed of 243 pregnant women subject to an external cephalic version, the ECV 
was successful in 94% of the cases when none of these factors occurred, as well as in at least 
20% of the cases if two of those factors occurred and 0% of the cases if the three factors took 
place.  
Nevertheless, other factors considered as significant independent predictors in the past, 
as the placental location, the backbone position, the breech type, the maternal body mass 
index and the fetal weight seem to be less significant if the three factors mentioned above 
are controlled (they are not independent factors). However, it must be taken into account 
that the usefulness of these indicators is still awaiting confirmation by further research.   
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Even though some projects reveal that the higher amniotic fluid volume is, the more 
successful ECV can be. This statement has not been proved yet and it can also imply a 
higher number of spontaneous revisions.  
Pregnant women should be informed that approximately 50% of those external versions 
performed by an experienced professional are successful, even though the results must be 
separately identified for each patient (level of recommendation B) (RCOG, 2006). 
11. Making the ECV easier 
The procedures that have proved their usefulness in randomized studies are only the 
tocolytics aiming at relaxing the uterus at the version.   
In a 2005 Cochrane's review, tocolytics were related to a reduction of the failure risk in 
external cephalic version both with nulliparous and multiparous women, as well as to a 
reduction in the caesarean rate. In the "tocolytic groups" the achievement of the external 
cephalic version in a minute and the fetal bradycardia was less common.  These results are 
valid for tocolytics such as ritodrine, salbutamol and terbutaline (both by an intravenous or 
subcutaneous injection).  However, no evidence has been proved in order to use other 
tocolytics suggested in other projects (such as the intravenous nitroglycerin, sublingual 
glyceryl trinitrate or nifidipine). Thus, pregnant women should be warned about the 
tocolytics adverse effects (evidence level Ia and recommendation level A).  
In the same revision it was concluded that despite the fact that many multiple studies 
have been carried out, there is not enough scientific evidence proving the use of epidural 
analgesia, vibroacoustic stimulation or amnioinfusion in order to facilitate the version. 
A small prospective study published in 2010 concluded that the factors increasing the 
probability of success and reducing the rate of adverse effects in ECV are a single attempt at 
the maneuver, total duration of the maneuver of less than 5minutes, and use of salbutamol 
as a uterine relaxant (Delgado et al, 2010). 
There were contradictory results regarding the outcomes using the epidural or spinal 
analgesia to facilitate the version maneuvers. Therefore, the use of regional analgesia in 
order to facilitate the external cephalic version cannot be recommended.  
In the case of the acoustic stimulation of the fetus, there is a small project which proved a 
significant reduction in the external cephalic version failure rate in midline fetal spine 
positions. Nevertheless, as this project is small, the confirmation of the results by other 
projects is necessary before including this procedure into the clinical practice.  
No randomized clinical studies on the amnioinfusion practices as a method to facilitate the 
external version were found.  
12. ECV: The right moment for its performance 
The external version should be performed as of the 37th week (at term). The reasons for this 
recommendation are the following: the fetus is mature and, in case any problem takes place, 
the labour can be induced easily. Moreover, the spontaneous cephalic versions without 
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trying the external cephalic version or the reversion after a successful external cephalic 
version are less common at term.   
The Cochrane’s meta-analysis on cephalic versions in fetus at term (at least 37 weeks) 
evidently prove that the possibility of breech presentation and the caesarean practice can be 
substantially reduced without significantly increasing the perinatal mortality.  As a result, 
there are many reasons for the clinical use of the external cephalic version at term (with the 
suitable precautions) in any pregnant woman where the cephalic vaginal delivery 
probability overcomes the version risk.    
However, another Cochrane’s meta-analysis in pregnancies at term indicated that the early 
external cephalic version (from the 32nd to the 37th week) has not proved any significant 
effect on the position of the fetus at term (from the 38th to the 40th week) or on the caesareans 
incidence or perinatal results.   In view of the absence of evidence on the effectiveness of the 
early external cephalic version and the existence of (observational) studies which relate it to 
higher risks, no procedure can be currently recommended. 
Controlled and randomized studies have established that external cephalic version at term 
increases the probability of cephalic presentation at delivery and that, therefore, the 
necessity of a caesarian is reduced. However, the success rates are low (particularly in North 
America and Europe). The ECV studies at term carried out in Africa expressed high success 
rates. However, these results were not repeated in the studies from North America and 
Europe. It was suggested that this situation could be caused by the pelvic structure 
differences in white women, making the fetus prematurely engage and, thus, hampering the 
ECV. 
In order to solve this problem and with the purpose of increasing the success rates, the 
University of Toronto carried out a pilot study to determinate if the ECV at preterm (at th 
34th or 35th week) could be more effective than when started at term (≥ the 37th-38th week). 
This study was aimed at reducing the breech presentation rates at delivery if the 
procedure was previously performed. If the breech presentation rate was finally reduced, 
an wider study to consider the caesarean rates, fetal results and neonatal adverse results 
should be carried out. It was observed an significant reduction both in the cephalic 
presentation rates at delivery (9,5%) and in the caesareans (7%). However, these results 
were not relevant enough since the sample was very small. No differences in the neonatal 
results from both groups were shown. Apart from that, the reversion rate in breech 
presentation was low in both groups. Besides, most of women stated that they could 
consider the ECV in prospective pregnancies. That shows an increase of the acceptance 
level (Hutton et al, 2003).  
These results show that the ECV at the 34th-35th week could be more effective than ECV at 
term. Taking into account that the caesarian rate decreased 9% (~10%) with ECV at the 
34th  week, 10 patients should be treated (NNT) in order to prevent 1 caesarian. This 
means that only 10 women would need a preterm ECV (instead of receiving a ECV at 
term) in order to avoid 1 caesarean.  However, these results must be reconfirmed by a 
wider study. The fetal safety and the preterm version must also be verified before 
recommending a change in the clinical practice.  The Early External Cephalic Version 2 Trial 
www.intechopen.com
 
From Preconception to Postpartum 
 
200 
project has been recently approved (in May, 2007). This project will indicate if early ECV 
is better than ECV at term in order to avoid the caesarean delivery (University of Toronto, 
2007). 
13. ECV: Adverse effects 
The external version is a procedure that is not exempt from potential problems. Nonetheless, 
if it is properly performed, the risk of complications is low. The Cochrane's systematic 
review on the external cephalic version in babies at term concluded that the ECV reduced 
breech presentations and caesareans, without expressing statistically significant differences 
on perinatal mortality. However, there is not enough evidence to specifically assess the risks 
related to the procedure. 
The available information from the isolated observational studies and classical obstetrics 
books describe many complications such as hemorrhage, rupture of membranes, umbilical 
cord arround the fetal neck, placental abruption, start of labour, fetomaternal transfusion, 
uterine rupture and fetal demise. The most common complication among the described 
complications is the fetal bradycardia which, as it has already been said, is spontaneously 
solved in most of the cases when the manoeuvre is stopped. It seems to be due to a 
temporary fetal hypoxia caused by an increased pressure generated by the uteroplacental 
blood flow alteration during the version manoeuvres. After the version, the nonreactive 
CTGR (Cardiotocography Registry), which are temporary as well, are less common. If the 
bradycardia continues, a caesarean must be urgently performed. For all these reasons, it is 
recommended to perform the technique in an appropriate room for the immediate care of 
the aforementioned complications. However, given the low rate of described complications, 
specifically incomparison with the vaginal delivery, it is not necessary to perform a patient’s 
presurgical preparation (previous absolute diet, premedication prior to general anesthesia or 
peripheral venous cannulation).  
Some temporary Doppler alterations in the umbilical and middle cerebral arteries, as well 
as an increase in the amniotic fluid volume after the version have also been described  The 
reasons for these alterations are currently unknown. Studies about the posible ECV effects 
over the fetal blood circulation revealed a reduction in the pulsatility of the middle 
cerebral artery. However, there were not any modifications in the umbilical artery. 
Therefore, it does not seem to change the placental blood flow. Furthermore, the 
reduction in the rate of pulsatility of the middle cerebral artery was more common in 
multiparous, in posterior placenta or if the procedure was difficult. However, it was not 
related to the fact that the version was successful (Lau et al, 2000). A recently released 
article associates the changes in the pulsatility rate with the pressure on the uterine wall 
during the manoeuvre and also reveals variations in the middle cerebral artery in cases of 
posterior placenta, as well as in the umbilical artery when it is lateral (Leun et al, 2004). In 
any case, it seems to be a physiological response and it has never been related to a 
negative perinatal result. 
Once the cephalic version has been completed, many complications have been proved at 
delivery, such as greater frequency of labor dystocia, risk of fetal suffering, caesarean caused 
by birth anomalies and induction failure. The reasons for these complications are unknown 
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and they are not clearly related to the version procedure itself. After having analyzed 169 
successful versions in a project, it was observed a caesarean rate at delivery 2,25 times 
higher in comparison with the control group (fetus with spontaneous cephalic presentation). 
This increase was due to the higher fetal suffering rate and dystocias. It was also proved an 
increase in the instrumental vaginal birth (Lau et al, 1997). A higher risk of dystocia and 
fetal suffering in cephalic presentation after version may require a more careful intrapartum 
monitoring.  
Given the absence of clinical evidence available about the possible adverse effects and their 
real consequences two meta-analyses have been recently released. The purpose of these 
analyses was to analyse the adverse effects related to the extreme version procedure, as well 
as to know its frequency. The most common adverse effects found were the CTGR 
alterations (between 1% and 47%, depending on the series), specially fetal bradycardia. Most 
of these alterations are temporary, as they are solved between the first 5 and 60 minutes. The 
prolonged decelerations that required an emergency caesarean only represented 1,1%, and 
in all cases the fetuses were born in good condition. There was no increase in the significant 
risk of nuchal cord in pregnant women subject to external version in comparison with the 
pregnant women with breech presentation where the version was not performed. The 
projects describe only 0,054% of cord prolapse cases (Nassar et al, 2006), which is a really 
low risk compared with the risk in breech or transverse presentation fetus with premature 
rupture of membranes. The vaginal bleeding after the version occured in approximately 
three in a thousand pregnants. The incidence of placenta abruption occurred in 0,12%, 
which is lower than the 0,34%, which represents the at term pregnant overall population. 
Other reviews, however, did not find any case in its series. Concerning the fetal adverse 
effects, the femoral fracture also has to be mentioned, occurring one only case among all of 
them. 
The incidence of fetal demise after the procedure was 1,64 in a thousand versions 
performed. Thus, it was not clearly related to the external version and none of the cases 
occurred during the first 24h after the procedure. Anyway, this figure is not higher than 
antepartum fetal demise (between the 36th and the 40th week) rate (6,2 in a thousand 
newborns). 
Concerning the maternal adverse effects found, the external version can be painful for the 
patient. Approximately 35% of the pregnants suffer mild discomfort during the version 
and 5% severe pain. The procedure may be stopped for this reason, and it has been 
observed that when the version fails the pain is higher than when it succeeds. The 
available data about the use of analgesia during the manoeuvre are still few. 4% suffered 
tachycardia or palpitations, which were solved one hour later without the use of 
medication. In less than 2% of the cases, it occurred fetomaternal transfusion. The results 
did not show any significant differences concerning the start of labour during the 24h 
after the version compared with the breech presentations where the version was not 
performed. 
Basically, the data released in the two only meta-analyses reveal a low complication rate and 
show the external cephalic version as a safe procedure. Nevertheless, new projects 
supporting the aforementioned results are strongly needed. 
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Pregnant women should be informed of the possible (although in a low rate) complications 
of the external version (recommendation level B).  
14. ECV: Quality indicators 
The auditable standards for the external version are: 
 Detection of antepartum breech presentation. 
 Percentage of patients with breech presentation who are offered the external version. 
 Version success figures. 
 Complications occurring during or after the maneuver. 
 Maternal experience of the version. 
15. ECV: Associated costs 
A 2001 British project analyses the hospital costs derived from the external version. The 
purpose was to determine the difference of costs between performing an external version, a 
vaginal delivery or a caesarean delivery for the breech presentations. The costs were 
calculated for the “accepted ECV” vs. “non-accepted ECV” option. Both options included 
the probable emergence of adverse effects, as well as the different deliveries (breech 
presentation, cephalic, planned caesarean, emergency caesarean, etc.) The results proved 
£248-£376 saving per patient. Therefore, offering ECV implies lower hospital costs than if it 
was not offered. An obstetrics service offering daily ECV will be cheaper than a service 
which does not offer it (James et al, 2001).  
A cost-benefit analysis was also carried out including the The Term Breech Trial data. 
Surprisingly, it demonstrated that healthcare costs in the caesarean group were less than 
those produced in the vaginal delivery group. It also proved that there were not any 
differences regarding parity. Even though the caesarean intrapartum costs were higher, the 
vaginal delivery patients need more antepartum and intrapartum care as well as the babies, 
who need more intensive and intermediate cares, apart from the costs related to the epidural 
analgesia.  Many studies expressing higher healthcare costs in induced labor or oxytocin 
stimulation have been published (Bost, 2003). These results show that the caesarean in 
breech presentation at term, despite being safer, it is also cheaper than vaginal labour 
(Palencia et al, 2006). However, this statement cannot be taken for granted, since the analysis 
did not take into account the long term costs (in prospective pregnancies, for instance) as 
well as the maternal risks. 
16. ECV: Alternatives 
Other methods used to correct the fetal position are acupuncture, homeopathy and postural 
methods. There is an awakening interest in exploring alternative medicines during 
pregnancy and labour. This interest is especially important in the case of external version 
alternatives since this is considered as s “dangerous” manoeuvre by pregnant women. The 
alternative medicine has become so important that Cochrane has carried out some reviews on 
the effectiveness of these methods, in particular, those referring to postural methods and the 
moxibustion use in cephalic version.  
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Throughout the history, midwives and doctors have used many different techniques 
referring to the best position to facilitate the cephalic version. However, few articles have 
been published about this topic in the medical literature.  The knee-chest position and the 
supine position with the pelvis elevated with a wedge-shaped cushion are the most 
common techniques. The available evidence from the controlled clinical trials is so far 
insufficient to uphold the use of postural methods (Hofmeyr et Kulier, 2000). 
Moxibustion is a type of Chinese medicine which involves burning a herb close to the skin 
in order to cause a heating sensation. It has also been stated that the acupuncture point 
called Bladder 67 (BL67) (or Zhiyin, according to its Chinese name) placed on the top of 
the fifth toe can correct breech presentations. How it works is totally unknown, but it 
seems to stimulate the production of maternal hormones (placental estrogens and 
prostaglandin) and the uterine contractions, as well as the fetal activity. In spite of not 
having found any adverse effects, Cochrane did not find enough evidence to prove that 
the moxibustion might be useful for correcting a breech presentation. The results suggest 
that moxibustion may be effective to reduce the external cephalic version need and caused 
a reduction in the use of oxytocin. However, some additional evidence is needed to 
confirm (or to reject) a benefit with respect to the breech presentation correction (Coyle et 
al, 2005; Hutton & Hofmeyr, 2006). 
Therefore, there is not enough scientific evidence to recommend neither postural 
methods nor moxibustion to facilitate the spontaneous cephalic version 
(recommendation level A). 
17. Conclusions 
The ECV is safe and useful for reducing caesarean rates. The external version success goes 
from 30% to 80%. The experience of the obstetrician who performed the technique plays a 
key role in ensuring success (Fandino et al, 2010). An obstetrics service offering daily ECV 
will be cheaper than a service which does not offer it (James et al, 2001). Tocolycs are 
recommended to be used during the manoeuvre to reduce adverse effects and increase the 
success rate.  
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